Burden of psychiatric disorders in the pediatric population

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
A ClavennaMaurizio Bonati

Abstract

In order to estimate the burden of mental disorders in a representative Italian pediatric population, an epidemiological study was performed using three administrative databases: a drug prescription, a hospital discharge form, and an outpatient ambulatory visit database. The population target was 1,616,268 children and adolescents under 18 years living in the Lombardy Region, Italy. A youth was defined as a case if during 2008 he/she received at least one psychotropic drug prescription or was hospitalized for a psychiatric disorder (International Classification of Disease codes 290-319), or attended a child neuropsychiatric outpatient unit for a visit and/or a psychological intervention or rehabilitation at least once. Epileptic children were excluded. In all, 63,550 youths (39.3 per 1000; 95%CI 39.1-39.7‰) were identified as users of health care resources for a putative mental disorder. The prevalence was higher in boys than in girls (47.0‰ versus 31.3‰) and the highest value was recorded in children 8 years old (60.2‰). A total of 59,987 youths (37.1‰) attended a child and adolescent neuropsychiatry service at least once, 3605 (2.2‰) were admitted to hospital, and 2761 (1.7‰) received at least one psychotropic drug prescripti...Continue Reading

References

Oct 5, 2001·Social Psychiatry and Psychiatric Epidemiology·A SouranderJ Piha
Aug 13, 2003·Archives of General Psychiatry·E Jane CostelloAdrian Angold
Aug 3, 2004·Pediatrics·Pietro PaneiAlessandro Zuddas
Nov 24, 2004·Journal of Affective Disorders·Mauro PercudaniLorenzo Petrovich
Apr 16, 2005·Psychotherapy and Psychosomatics·Mauro PercudaniLorenzo Petrovich
Sep 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·E Jane CostelloAdrian Angold
Mar 8, 2006·Archives of General Psychiatry·Tarek A HammadJudith Racoosin
Oct 10, 2006·European Journal of Pediatrics·Antonio ClavennaMaurizio Bonati
Dec 14, 2006·Clinical Drug Investigation·Shlomo VinkerAsher Elhayany
Jun 7, 2007·Pharmacoepidemiology and Drug Safety·Anita C VolkersLiset van Dijk
Jul 31, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tatiana UsalaMaurizio Bonati
Sep 7, 2007·Lancet·Shekhar SaxenaHarvey Whiteford
Jan 29, 2008·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Myron L Belfer
Feb 6, 2008·Social Psychiatry and Psychiatric Epidemiology·Barbara MaughanRobert Goodman
Sep 26, 2008·BMJ : British Medical Journal·Tim KendallUNKNOWN Guideline Development Group
Sep 27, 2008·Child and Adolescent Psychiatry and Mental Health·Julie M ZitoSatish C Valluri
Nov 15, 2008·Journal of Epidemiology and Community Health·C Barbui, M Tansella
Jan 24, 2009·European Child & Adolescent Psychiatry·Alessandra FrigerioMassimo Molteni
Jul 15, 2009·European Journal of Clinical Pharmacology·Simona MonteGianni Tognoni
Aug 5, 2009·Archives of General Psychiatry·Mark Olfson, Steven C Marcus
Dec 29, 2009·Journal of Child and Adolescent Psychopharmacology·Helga ZoëgaMatthías Halldórsson
Jul 14, 2010·Psychiatry Research·Marie TournierYola Moride
Sep 24, 2010·Acta Psychiatrica Scandinavica·H ZoëgaJ E Martikainen
Dec 15, 2010·European Journal of Clinical Pharmacology·Elisabetta PoluzziNicola Montanaro
Jan 12, 2011·Annual Review of Public Health·Douglas P JutteMarni D Brownell
May 4, 2011·European Journal of Clinical Pharmacology·Anna DidoniUNKNOWN Lombardy ADHD Registry Group
May 11, 2011·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Jodi MorrisShekhar Saxena
May 25, 2011·BMC Pediatrics·Antonio ClavennaMaurizio Bonati
Oct 18, 2011·Pediatrics·UNKNOWN Subcommittee on Attention-Deficit/Hyperactivity DisorderSusanna Visser
Mar 16, 2012·The American Journal of Psychiatry·Samuel H Zuvekas, Benedetto Vitiello

❮ Previous
Next ❯

Citations

May 29, 2015·European Child & Adolescent Psychiatry·Daniele PiovaniMaurizio Bonati
Apr 4, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Mark J MillanSven Ove Ögren
Sep 17, 2016·Drug Development Research·Sarah KhanShahida Khan
Mar 16, 2017·Psychiatry and Clinical Neurosciences·Daisuke ShinjoKiyohide Fushimi
Dec 20, 2014·Journal of Attention Disorders·Laura RealeMaurizio Bonati
Sep 1, 2015·Journal of Attention Disorders·Maurizio BonatiUNKNOWN Lombardy ADHD Group
May 21, 2017·European Child & Adolescent Psychiatry·Laura RealeUNKNOWN Lombardy ADHD Group
Jun 8, 2018·European Child & Adolescent Psychiatry·Maurizio BonatiUNKNOWN Lombardy ADHD Group
May 16, 2017·Acta Psychiatrica Scandinavica·C J BachmannD Taylor
Nov 28, 2016·European Journal of Clinical Pharmacology·Daria PutignanoMaurizio Bonati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here